Rankings
▼
Calendar
DAWN FY 2025 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$158M
+20.6% YoY
Gross Profit
$141M
89.1% margin
Operating Income
-$128M
-80.8% margin
Net Income
-$107M
-67.8% margin
EPS (Diluted)
$-1.04
Cash Flow
Operating Cash Flow
-$104M
Free Cash Flow
-$104M
Stock-Based Comp.
$44M
Balance Sheet
Total Assets
$508M
Total Liabilities
$67M
Stockholders' Equity
$441M
Cash & Equivalents
$197M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$158M
$131M
+20.6%
Gross Profit
$141M
$126M
+12.0%
Operating Income
-$128M
-$217M
+41.2%
Net Income
-$107M
-$95M
-12.4%
← Q4 2024
All Quarters
Q1 2025 →